As focal amplification was mainly driven by ecDNA (56), the detection of ERBB2 and EGFR ecDNAs should be considered as potential prognostic biomarkers in gastric cardia adenocarcinoma. This evidence concerns the gene EGFR and gastric cardia adenocarcinoma.